AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11079734 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanalysis of overall health findings in infants without a family risk of allergies
Number of subjects: 1130
Study 8667280 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmandibular implant (TMI)
Number of subjects: 88
Study 8667280 — intervention group
Group type: EXPERIMENTAL
Intervention: IMZ implant system
Number of subjects: 88
Study 8667280 — intervention group
Group type: EXPERIMENTAL
Intervention: Brånemark system (BRA)
Number of subjects: 88
Study 8667280 — intervention group
Group type: COMPARATOR
Intervention: All implant systems (TMI, IMZ, BRA)
Number of subjects: 88
Study 1866069 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprophane membrane
Number of subjects: 0
Study 1866069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylenevinylalcohol, polycarbonate, polymethylmethacrylate, acrylonitrile membranes
Number of subjects: 0
Study 1866069 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysulphone and polyacrylonitrile membranes
Number of subjects: 0
Study 6743781 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational oral formulation of flurazepam
Number of subjects: 0
Study 6743781 — intervention group
Group type: COMPARATOR
Intervention: Commercially available product of flurazepam
Number of subjects: 0
Study 6743781 — intervention group
Group type: EXPERIMENTAL
Intervention: N-1-desalkylflurazepam levels
Number of subjects: 0
Study 30005843 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 15
Study 29255960 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated Pivotal Response Training (PRT)
Number of subjects: 11
Study 27076184 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly dihydroartemisinin-piperaquine (DP)
Number of subjects: 469
Study 27076184 — intervention group
Group type: COMPARATOR
Intervention: Daily trimethoprim-sulfamethoxazole
Number of subjects: 469
Study 27076184 — intervention group
Group type: COMPARATOR
Intervention: Monthly sulfadoxine-pyrimethamine
Number of subjects: 469
Study 27076184 — intervention group
Group type: COMPARATOR
Intervention: No chemoprevention
Number of subjects: 469
Study 27076184 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 469
Study 27076184 — intervention group
Group type: EXPERIMENTAL
Intervention: HEU compared to HUU
Number of subjects: 469
Study 26410876 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular brachytherapy (EVBT)
Number of subjects: 44
Study 26410876 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty (PTA)
Number of subjects: 44
Study 23588438 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic mixture of 50% inulin and 50% fructo-oligosaccharide
Number of subjects: 31
Study 23588438 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 g of maltodextrin twice daily)
Number of subjects: 31
Study 20424500 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme for general practitioners (The Extended Reattribution and Management model)
Number of subjects: 701
Study 20424500 — intervention group
Group type: COMPARATOR
Intervention: Control group (GPs not trained)
Number of subjects: 701
Study 18551024 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 223
Study 18551024 — intervention group
Group type: COMPARATOR
Intervention: Control (current medication)
Number of subjects: 223
Study 15843449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular glucocorticoid treatment with 24 hour bed rest
Number of subjects: 20
Study 15843449 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular glucocorticoid treatment with normal activity
Number of subjects: 20
Study 15843449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular glucocorticoid treatment (both groups)
Number of subjects: 20
Study 12392871 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized reminders recommending individualized changes in therapy
Number of subjects: 2000
Study 12392871 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed discussion by endocrinologists providing feedback on performance
Number of subjects: 2000
Study 12392871 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2000
Study 10551706 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 1016
Study 10551706 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillators (ICDs)
Number of subjects: 1016
Study 7738291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% carteolol
Number of subjects: 50
Study 7738291 — intervention group
Group type: COMPARATOR
Intervention: 0.1% timolol
Number of subjects: 50
Study 1971234 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic villus sampling (CVS)
Number of subjects: 0
Study 1971234 — intervention group
Group type: COMPARATOR
Intervention: Amniocentesis
Number of subjects: 0
Study 6138071 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg midazolam
Number of subjects: 60
Study 6138071 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 tablet Vesparax (50 mg hydroxyzine, 150 mg secobarbital, 50 mg brallobarbital)
Number of subjects: 60
Study 6138071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31996179 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent-caregiver dyads reporting IPV and VAC
Number of subjects: 535
Study 31996179 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent-caregiver dyads reporting IPV
Number of subjects: 535
Study 31996179 — intervention group
Group type: EXPERIMENTAL
Intervention: Female caregiver-adolescent dyads with both VAC and IPV
Number of subjects: 535
Study 31996179 — intervention group
Group type: EXPERIMENTAL
Intervention: Male caregiver-adolescent dyads with both VAC and IPV
Number of subjects: 535
Study 31376801 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective bilateral transcranial direct current stimulation (20 min, 2 mA)
Number of subjects: 13
Study 31376801 — intervention group
Group type: COMPARATOR
Intervention: Sham bilateral transcranial direct current stimulation
Number of subjects: 13
Study 28894070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy for insomnia (CBT‐I) using mobile SNS, provided once a week for 60 minutes over six weeks
Number of subjects: 55
Study 28894070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study 25918972 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of donepezil and ninjin'yoeito (NYT)
Number of subjects: 23
Study 25918972 — intervention group
Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 23
Study 24315962 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (ferric hydroxide-polymaltose complex, 6mg/kg Fe(3+)/day) for 1-6 months
Number of subjects: 65
Study 24315962 — intervention group
Group type: COMPARATOR
Intervention: Control group (35 infants)
Number of subjects: 65
Study 23079898 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of neuroticism and extraversion
Number of subjects: 602
Study 23079898 — intervention group
Group type: COMPARATOR
Intervention: Low levels of neuroticism and extraversion
Number of subjects: 602
Study 19440890 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-assisted Sadness programme (CaCCBT)
Number of subjects: 45
Study 19440890 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 45
Study 22108262 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional review plus an additional review looking for missing items from reporting guidelines (n=51)
Number of subjects: 92
Study 22108262 — intervention group
Group type: COMPARATOR
Intervention: Conventional reviews alone (n=41)
Number of subjects: 92
Study 22108262 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional review suggestions adherence (n=51)
Number of subjects: 92
Study 16410944 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (Group B)
Number of subjects: 76
Study 16410944 — intervention group
Group type: COMPARATOR
Intervention: Routine recommendations (Group A)
Number of subjects: 76
Study 11845867 — intervention group
Group type: EXPERIMENTAL
Intervention: [1-deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin
Number of subjects: 218
Study 11845867 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 218
Study 11845867 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-channel antagonists (nifedipine, diltiazem, verapamil)
Number of subjects: 218
Study 11845867 — intervention group
Group type: COMPARATOR
Intervention: Control (AVP-induced contraction)
Number of subjects: 218
Study 10082500 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril (daily dose titrated between 2.5 and 20 mg)
Number of subjects: 59
Study 10082500 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (daily dose titrated between 12.5 and 100 mg)
Number of subjects: 59
Study 7740014 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch + active gum (group 1)
Number of subjects: 374
Study 7740014 — intervention group
Group type: EXPERIMENTAL
Intervention: Active nicotine patch + placebo gum (group 2)
Number of subjects: 374
Study 7740014 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch + gum (group 3)
Number of subjects: 374
Study 2344090 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% povidone-iodine soak
Number of subjects: 29
Study 2344090 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline soak
Number of subjects: 29
Study 2344090 — intervention group
Group type: COMPARATOR
Intervention: No soak (control)
Number of subjects: 29
Study 7362094 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled diluent
Number of subjects: 2
Study 7362094 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 2
Study 7362094 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated spirometry
Number of subjects: 2
Study 7362094 — intervention group
Group type: COMPARATOR
Intervention: Body plethysmograph
Number of subjects: 2
Study 29860057 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg BID
Number of subjects: 52
Study 29860057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 23834587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 150
Study 23834587 — intervention group
Group type: COMPARATOR
Intervention: Selective Serotonin Reuptake Inhibitor (SSRI)
Number of subjects: 150
Study 23834587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy + SSRI (CBT+SSRI)
Number of subjects: 150
Study 23184627 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 0
Study 23184627 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 20036048 — intervention group
Group type: EXPERIMENTAL
Intervention: Inside-out transobturator tape (TVT-O)
Number of subjects: 341
Study 20036048 — intervention group
Group type: COMPARATOR
Intervention: Outside-in transobturator tape (ARIS)
Number of subjects: 341
Study 18503531 — intervention group
Group type: EXPERIMENTAL
Intervention: Junior Detective Training Program (7-week program including a computer game, small group sessions, parent training sessions, and teacher handouts)
Number of subjects: 49
Study 18503531 — intervention group
Group type: EXPERIMENTAL
Intervention: Junior Detective Training Program
Number of subjects: 49
Study 18503531 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 49
Study 15897160 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical immunotherapy with squaric acid dibutylester (SADBE)
Number of subjects: 54
Study 15897160 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study 12550076 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-677 25mg daily
Number of subjects: 12
Study 10506267 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin estolate (40 mg/kg/day in 3 divided doses; maximum dose 1 g) for 10 days
Number of subjects: 310
Study 10506267 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 310
Study 8529510 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 354
Study 8529510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 1952134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoclopramide (10 mg)
Number of subjects: 15
Study 1952134 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study 6119169 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 62
Study 6119169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 31535510 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding during BCG vaccination
Number of subjects: 100
Study 31535510 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 100
Study 27077238 — intervention group
Group type: EXPERIMENTAL
Intervention: Siblings Are Special (SIBS) intervention, 12 weekly afterschool sessions (90 min each) and 3 family nights (2 hr each)
Number of subjects: 54
Study 27077238 — intervention group
Group type: COMPARATOR
Intervention: No-attention control
Number of subjects: 54
Study 24708747 — intervention group
Group type: EXPERIMENTAL
Intervention: Option Grid
Number of subjects: 72
Study 24708747 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study 22592331 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 min modified sham feeding (MSF) with 100 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26
Study 22592331 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 min modified sham feeding (MSF) with 800 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26
Study 22592331 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min modified sham feeding (MSF) with 100 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26
Study 22592331 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min modified sham feeding (MSF) with 800 ml intragastrically infused liquid (isocaloric, 99 kcal, 100 ml/min)
Number of subjects: 26
Study 22592331 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no oral or gastric stimulation)
Number of subjects: 26
Study 19834718 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene 100 mg + delayed low dose gonadotropin + flexible GnRH antagonist administration
Number of subjects: 243
Study 19834718 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonist + gonadotropin
Number of subjects: 243
Study 18599569 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone (IVTA)
Number of subjects: 43
Study 18599569 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 43
Study 16079209 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI below 20
Number of subjects: 3110
Study 16079209 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 20-22
Number of subjects: 3110
Study 16079209 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 24
Number of subjects: 3110
Study 16079209 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 22 for men and 20 for women
Number of subjects: 3110
Study 16079209 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude mortality rates
Number of subjects: 3110
Study 12162754 — intervention group
Group type: EXPERIMENTAL
Intervention: HFA-BDP
Number of subjects: 473
Study 12162754 — intervention group
Group type: COMPARATOR
Intervention: CFC-BDP
Number of subjects: 473
Study 9717597 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium for non-smokers
Number of subjects: 40
Study 9717597 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium for smokers
Number of subjects: 40
Study 7868405 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 239
Study 7868405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 2568848 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 1.1 mg
Number of subjects: 40
Study 2568848 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 2.0 mg
Number of subjects: 40
Study 2568848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.25 mg
Number of subjects: 40
Study 2568848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.5 mg
Number of subjects: 40
Study 781187 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 781187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31813104 — intervention group
Group type: EXPERIMENTAL
Intervention: McPhail traps with Bio Anastrepha® alone
Number of subjects: 12
Study 31813104 — intervention group
Group type: EXPERIMENTAL
Intervention: McPhail traps with Bio Anastrepha® combined with different doses of insecticide
Number of subjects: 12
Study 31813104 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 12
Study 29113572 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized training instructions during 12 weeks (3×/week)
Number of subjects: 42
Study 28319453 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination education intervention
Number of subjects: 1252
Study 25548124 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led problem-solving therapy (PST), 12 telephone-based sessions over 6 months.
Number of subjects: 254
Study 25548124 — intervention group
Group type: COMPARATOR
Intervention: Usual care from primary care providers.
Number of subjects: 254
Study 22406837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish diet
Number of subjects: 14
Study 22406837 — intervention group
Group type: COMPARATOR
Intervention: Vegetarian diet
Number of subjects: 14
Study 22406837 — intervention group
Group type: EXPERIMENTAL
Intervention: Meat diet
Number of subjects: 14
Study 22406837 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-meat-half-fish diet
Number of subjects: 14
Study 21833720 — intervention group
Group type: EXPERIMENTAL
Intervention: RP101 (Brivudine) at a dose of 500 mg/day
Number of subjects: 0
Study 21833720 — intervention group
Group type: EXPERIMENTAL
Intervention: RP101 (Brivudine) at a dose of 760 mg/day
Number of subjects: 0
Study 18484984 — intervention group
Group type: EXPERIMENTAL
Intervention: D1 (1% chloramine T)
Number of subjects: 60
Study 18484984 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 (0.01% fluorosurfactant)
Number of subjects: 60
Study 18484984 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 60
Study 16713432 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg plus HRT (conjugated equine estrogen 0.625 mg, medroxyprogesterone 5 mg, elemental calcium 500 mg)
Number of subjects: 151
Study 16713432 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg plus HRT
Number of subjects: 151
Study 16713432 — intervention group
Group type: COMPARATOR
Intervention: HRT only
Number of subjects: 151
Study 14656750 — intervention group
Group type: EXPERIMENTAL
Intervention: Information delivered by junior physicians
Number of subjects: 220
Study 14656750 — intervention group
Group type: COMPARATOR
Intervention: Information delivered by senior physicians
Number of subjects: 220
Study 11703474 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 200
Study 11703474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 9738550 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based intervention (CB)
Number of subjects: 67
Study 9738550 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention (HB)
Number of subjects: 67
Study 9738550 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed-treatment)
Number of subjects: 67
Study 7981929 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg resin‐bound diclofenac (resinate)
Number of subjects: 16
Study 7981929 — intervention group
Group type: COMPARATOR
Intervention: Enteric‐coated tablets containing 75 mg of diclofenac
Number of subjects: 16
Study 7981929 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (resinate and enteric-coated tablets)
Number of subjects: 16
Study 2689506 — intervention group
Group type: EXPERIMENTAL
Intervention: 100mg Mifepristone (RU 486) given morning and evening for 48 hours
Number of subjects: 40
Study 2689506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31522953 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge education designed according to the Model of Living
Number of subjects: 144
Study 29932814 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal vitamin A supplementation
Number of subjects: 306
Study 27513920 — intervention group
Group type: EXPERIMENTAL
Intervention: Fracture reduction plus application of autologous mesenchymal stem cells (AMSCs)
Number of subjects: 20
Study 27513920 — intervention group
Group type: COMPARATOR
Intervention: Fracture reduction only (Control)
Number of subjects: 20
Study 26312886 — intervention group
Group type: EXPERIMENTAL
Intervention: Any form of image guidance (triplanar display, always-on solid overlay, always-on wire mesh overlay, on-demand inverse realism overlay)
Number of subjects: 50
Study 26312886 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented reality systems (always-on wire mesh, on-demand inverse realism)
Number of subjects: 50
Study 26312886 — intervention group
Group type: EXPERIMENTAL
Intervention: Always-on solid overlay
Number of subjects: 50
Study 26312886 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire mesh and on-demand overlays
Number of subjects: 50
Study 26312886 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire mesh and inverse realism overlays
Number of subjects: 50
Study 26312886 — intervention group
Group type: COMPARATOR
Intervention: No image guidance
Number of subjects: 50
Study 26312886 — intervention group
Group type: COMPARATOR
Intervention: Triplanar display
Number of subjects: 50
Study 24039173 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variants in ADAMTS16
Number of subjects: 2246
Study 24039173 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric symptom severity
Number of subjects: 2246